
About Resplice
Resplice is a Healthcare company based in Hyderabad (India) founded in 2022. Conducts clinical trials for autism using microbiota transfer therapy. It operates on a B2B model. The company has 1 employees. Its Indian entity Providence Microbiome Research Center Private Limited reported revenue of βΉ4.3 Lakh. Resplice offers products and services including Gut Symbiont Restoration Therapy. Its focus areas include Health, Medical Research, Clinical Trials and Microbiome Studies.
Company details
GSRT focuses on developing gut symbiont restoration therapy to treat autism spectrum disorders through faecal microbiota transfer. Based in Hyderabad, India, they run academic clinical trials at St. Theresa Hospital, assessing gut microbiome and epigenetic changes. Collaborations with institutions like CDFD support studies on autisms causes and potential prevention. The initiative aims to explore gene-environment interactions and improve therapeutic outcomes.
- Headquarters Hyderabad, India
- Employees 1
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website gsrt.co.in
- Legal Name Providence Microbiome Research Center Private Limited
- Date of Incorporation 11 Sep, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹4.3 Lakh
FY 2024 · +194% YoY
- Net Loss-₹5.8 Lakh
FY 2024 · -135% margin
- EBITDA-₹5.8 Lakh
FY 2024 · -135% margin
- Employee Count1
Associated legal entities of Resplice
Resplice operates through Providence Microbiome Research Center Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Providence Microbiome Research Center Private Limited CIN U73100TG2020PTC143763 | Active | 11 Sep 2020 | Hyderabad, Telangana | ₹0.0 Cr | 2 | View details |
Products & Services of Resplice
Resplice offers a comprehensive portfolio of products and services, including Gut Symbiont Restoration Therapy.
Uses faecal microbiota transfer to address autism symptoms
Board of directors of Providence Microbiome Research Center Private Limited (Resplice)
Providence Microbiome Research Center Private Limited is the primary company behind Resplice. The board of Providence Microbiome Research Center Private Limited currently have 2 directors; the longest-serving is Chandrashekhar Thodupunuri, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chandrashekhar Thodupunuri DIN 08873815 | Director | 11 Sep 2020 | 6 yrs 2 mo | Providence Microbiome Research Center Private Limited |
| Keerthi Sarabu DIN 08873816 | Director | 11 Sep 2020 | 6 yrs 2 mo | Providence Microbiome Research Center Private Limited |
Financials of Resplice
Figures of Providence Microbiome Research Center Private Limited, the primary company behind Resplice, for FY 2024. Revenue was ₹4.3 Lakh (+194% year on year). Net loss was -₹5.8 Lakh (-135% margin). EBITDA was -₹5.8 Lakh (-135% margin).
- ₹4.3 LakhRevenue · FY 2024 · +194% YoY
- -₹5.8 LakhNet loss · -135% margin
- -₹5.8 LakhEBITDA · -135% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Providence Microbiome Research Center Private Limited are on its company page.
Detailed financial statements for Resplice
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Resplice
Resplice was founded in 2022.
Resplice is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Resplice has 1 employees.
The primary company behind Resplice, Providence Microbiome Research Center Private Limited, reported revenue of βΉ4.3 Lakh for FY 2024, up 194% year on year.
GSRT focuses on developing gut symbiont restoration therapy to treat autism spectrum disorders through faecal microbiota transfer. Based in Hyderabad, India, they run academic clinical trials at St. Theresa Hospital, assessing gut microbiome and epigenetic changes. Collaborations with institutions like CDFD support studies on autisms causes and potential prevention. The initiative aims to explore gene-environment interactions and improve therapeutic outcomes.
Resplice offers Gut Symbiont Restoration Therapy.
Resplice operates through Providence Microbiome Research Center Private Limited.
The legal entities of Resplice currently have 2 directors, including Chandrashekhar Thodupunuri, Keerthi Sarabu.